Navigation

Lung cancer (small-cell, second line treatment) - topotecan

Topotecan for the treatment of small cell lung cancer

Status: History
Expected date of issue: November 2009
Referral date: June 2008
Process: MTA
Topic area:
  • Cancer
  • Respiratory
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Helen Knight/Scott Goulden
Communications manager: Sarita Tamber
Project manager: Laura Malone
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 05 December 2008
1st appraisal committee meeting: 11 June 2009
2nd appraisal committee meeting: 12 August 2009
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • GlaxoSmithKline (oral and intravenous topotecan)

Patient/carer groups

  • Breathe Easy
  • Macmillan Cancer Support
  • Roy Castle Lung Cancer Foundation
  • South Asian Health Foundation

Professional groups

  • British Thoracic Society
  • Royal College of Nursing
  • Royal College of Physicians (Medical Oncology Joint Special Committee)

Others

  • Department of Health
  • Berkshire East Teaching PCT
  • Powys LHB PCT
  • Welsh Assembly Government

General

  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

Comparator manufacturers

  • Pfizer (cyclophosphamide, doxorubicin)

Relevant research groups

  • None

Assessment Groups

  • Southampton Technology Assessment Group, University of Southampton
  • National Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA Programme)

Associated Guideline Groups

  • National Collaborating Centre for Cancer

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.